---
title: A human lymphoma organoid model for evaluating and targeting the follicular
  lymphoma tumor immune microenvironment
date: '2024-02-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38402619/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240226170444&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Heterogeneity in the tumor microenvironment (TME) of follicular lymphomas
  (FLs) can affect clinical outcomes. Current immunotherapeutic strategies, including
  antibody- and cell-based therapies, variably overcome pro-tumorigenic mechanisms
  for sustained disease control. Modeling the intact FL TME, with its native, syngeneic
  tumor-infiltrating leukocytes, is a major challenge. Here, we describe an organoid
  culture method for cultivating patient-derived lymphoma organoids (PDLOs), which
  ...
disable_comments: true
---
Heterogeneity in the tumor microenvironment (TME) of follicular lymphomas (FLs) can affect clinical outcomes. Current immunotherapeutic strategies, including antibody- and cell-based therapies, variably overcome pro-tumorigenic mechanisms for sustained disease control. Modeling the intact FL TME, with its native, syngeneic tumor-infiltrating leukocytes, is a major challenge. Here, we describe an organoid culture method for cultivating patient-derived lymphoma organoids (PDLOs), which ...